Physiomics PLC Director Dealing (4939Z)

TIDMPYC

RNS Number : 4939Z

Physiomics PLC

21 May 2021

21 May 2021

Physiomics plc

("Physiomics") or ("the Company")

Director Dealing

The Company announces that Dr Jim Millen, Chief Executive Officer of Physiomics, has transferred, for no consideration, 242,287 ordinary shares of 0.4p each in the Company ("Ordinary Shares") from a brokerage account with James Brearley & Sons Limited to an account with Interactive Investors. The Ordinary Shares remain beneficially owned by Dr Millen.

Dr Millen's holding in the Company therefore remains 1,384,393 Ordinary Shares, representing approximately 1.42 per cent. of the Company's issued share capital.

Enquiries:

Physiomics plc

Dr Jim Millen, CEO

[phone]

Hybridan LLP (broker)

Claire Louise Noyce

[phone]

Strand Hanson Ltd (NOMAD)

James Dance & James Bellman

[phone]

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 
 1    Details of the person discharging managerial responsibilities/person closely associated 
 a)   Name                                                              James Millen 
     ----------------------------------------------------------------  ----------------------------- 
 2    Reason for the notification 
     ----------------------------------------------------------------------------------------------- 
 a)   Position/status                                                   Director, CEO 
     ----------------------------------------------------------------  ----------------------------- 
 b)   Initial notification/ Amendment                                   Initial notification 
     ----------------------------------------------------------------  ----------------------------- 
 3    Details of the issuer, emission allowance market participant, auction platform, auctioneer 
       or auction monitor 
     ----------------------------------------------------------------------------------------------- 
 a)   Name                                                              Physiomics plc 
     ----------------------------------------------------------------  ----------------------------- 
 b)   LEI                                                               213800A71DSZ6ABMTQ91 
     ----------------------------------------------------------------  ----------------------------- 
 4    Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
       each type of transaction; (iii) each date; and (iv) each place where transactions have been 
       conducted 
     ----------------------------------------------------------------------------------------------- 
 a)   Description of the financial instrument, type of instrument       Ordinary share 
 
       Identification code 
                                                                         GB00BDR6W943 
     ----------------------------------------------------------------  ----------------------------- 
 b)   Nature of the transaction                                         Transfer of Ordinary Shares 
     ----------------------------------------------------------------  ----------------------------- 
 c)   Price(s) and volume(s)                                             Price(s)    Volume(s) 
                                                                          Nil         242,287 
                                                                                     ---------- 
     ----------------------------------------------------------------  ----------------------------- 
 d)    Aggregated information 
         *    Aggregated volume                                           242,287 
                                                                          Nil 
 
         *    Price 
     ----------------------------------------------------------------  ----------------------------- 
 e)   Date of the transaction                                           21 May 2021 
     ----------------------------------------------------------------  ----------------------------- 
 f)   Place of the transaction                                          XLON, AIM 
     ----------------------------------------------------------------  ----------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHABMATMTJTBTB

(END) Dow Jones Newswires

May 21, 2021 11:40 ET (15:40 GMT)